BIO-PHARMA(UK) LIMITEDActive

Company number 08073073Private limited companyIncorporated 2012

Key figures

−£25,941-180.3%
Net assets 2024/25
-75 k-50 k-25 k025 k50 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, BIO-PHARMA(UK) LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand5,997————
Total assets34,813189,315207,325208,945—
Total liabilities—223,109233,491241,251—
Net assets / total equity-51,44233,79426,16632,306-25,941
Average number of employees33233

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

This company sells stuff to other companies

As described in the company's latest filed accounts.

Summary: BIO-PHARMA(UK) LIMITED

Company

BIO-PHARMA(UK) LIMITED is a private limited company registered with Companies House under company number 08073073. It was incorporated on 17 May 2012. Its status is active. The registered office is in Castleford (WF10). Its nature of business (SIC 2007) is other retail sale in non-specialised stores (47190), retail sale of cosmetic and toilet articles in specialised stores (47750).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files micro-entity accounts. Net assets were −£25,941, down 180.3% on the previous year. The company had an average of 3 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 5 Dec 2026.